EXACT Sciences (EXAS) Stock: Flying On Pfizer (PFE) Collaboration
EXACT Sciences Corporation (NASDAQ: EXAS) is having an overwhelmingly strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced that it has entered into an agreement with Pfizer Inc. (NYSE: PFE) surrounding its proprietary Cologuard cancer screening test. Of course, the news excited investors, sending the … Read more